CN Patent

CN101730700A — 用作蛋白激酶抑制剂的稠合杂环化合物

Assigned to Abbott GmbH and Co KG · Expires 2010-06-09 · 16y expired

What this patent protects

本发明公开了抑制Aurora激酶的式(I)化合物、含有所述化合物的组合物以及使用所述化合物治疗疾病的方法。

USPTO Abstract

本发明公开了抑制Aurora激酶的式(I)化合物、含有所述化合物的组合物以及使用所述化合物治疗疾病的方法。

Drugs covered by this patent

acalabrutinib-maleate (ACALABRUTINIB MALEATE)

Patent Metadata

Patent number: CN101730700A
Jurisdiction: CN
Classification: —
Expires: 2010-06-09
Drug substance claim: No
Drug product claim: No
Assignee: Abbott GmbH and Co KG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.